To meet the diagnostic criteria for cEDS, a person must meet: Major criterion 1 AND major criterion 2 OR Major criterion 1 AND three or more minor criteria Major Criteria Skin hyperextensibility and atrophic scarring Generalized joint hypermobility Minor Criteria Easy bruising Soft, doughy skin Skin fragility (or traumatic splitting) Molluscoid pseudotumors Subcutaneous spheroids Hernia (or history thereof) Epicanthal folds Complications of joint hypermobility (e.g., sprains, dislocations/subluxations, pain, flexible flatfoot) Family history of a first-degree relative who meets clinical criteria Genetic testing is used to see if a person has a genetic variant that causes vEDS

Key Benefits Activates collagen I, III, and elastin gene expression for tissue maintenance and repair Inhibits matrix metalloproteinases (MMPs) that destroy periodontal ligament fibers in periodontitis Reduces oxidative stress and inflammation in gingival and TMJ tissue Supports TMJ articular disc collagen remodeling and joint capsule integrity Accelerates wound healing following periodontal surgery Natural plasma levels decline with age supplementation addresses this biological deficit Delivery Methods Subcutaneous Injection Most effective systemic delivery administered per your prescribed protocol Topical / Local Application Applied directly to gingival tissue in some periodontal protocols in-office or as prescribed Note: GHK-Cu is often combined with BPC-157 or Thymosin Beta-4 in multi-peptide TMJ or periodontal protocols for synergistic collagen support and anti-inflammatory effect

These reactions are generally temporary, with swelling lasting three to five days and bruising for one to two weeks
TB-500 uses standard bacteriostatic water
Not always
(1970) Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy National Institute of Diabetes and Digestive and Kidney Diseases (2018) Tesamorelin Vauga P, Kuma M, Stojkoviov D, et al